OBJECTIVE: Retrospective analysis of feasibility, safety and advantages of device closure of patent ductus arteriosus (PDA) using only venous access. BACKGROUND: Arterial access for transcatheter device closure of PDA has been a standard practice, but has inherent complications, especially in infants. METHOD: Records of patients who underwent PDA device closure from 2004 to 2012 were reviewed. Echocardiography was used for patient selection and for assessment of procedural outcome. RESULT: 151 out of 179 patients underwent PDA device closure with venous access alone, weighing 2.2-58 kg with half <10 kg and follow up of 6 months-8 years. Fluoroscopic time ranged from 2.2 to 16 min. Immediate closure was achieved in 146 patients. Two patients had new-onset left pulmonary artery turbulence and one had residual flow. CONCLUSION: PDA device closure without arterial access can be accomplished safely and effectively in vast majority of patients including infants.
OBJECTIVE: Retrospective analysis of feasibility, safety and advantages of device closure of patent ductus arteriosus (PDA) using only venous access. BACKGROUND: Arterial access for transcatheter device closure of PDA has been a standard practice, but has inherent complications, especially in infants. METHOD: Records of patients who underwent PDA device closure from 2004 to 2012 were reviewed. Echocardiography was used for patient selection and for assessment of procedural outcome. RESULT: 151 out of 179 patients underwent PDA device closure with venous access alone, weighing 2.2-58 kg with half <10 kg and follow up of 6 months-8 years. Fluoroscopic time ranged from 2.2 to 16 min. Immediate closure was achieved in 146 patients. Two patients had new-onset left pulmonary artery turbulence and one had residual flow. CONCLUSION: PDA device closure without arterial access can be accomplished safely and effectively in vast majority of patients including infants.
Authors: Robert H Pass; Ziyad Hijazi; Daphne T Hsu; Veronica Lewis; William E Hellenbrand Journal: J Am Coll Cardiol Date: 2004-08-04 Impact factor: 24.094
Authors: J W Moore; L George; S E Kirkpatrick; J W Mathewson; R L Spicer; K Uzark; A Rothman; P A Cambier; M C Slack; W C Kirby Journal: J Am Coll Cardiol Date: 1994-03-01 Impact factor: 24.094
Authors: Ali A Alakhfash; Ali Jelly; Abdulrahman Almesned; Abdullah Alqwaiee; Mansour Almutairi; Sherif Salah; Mahmoud Hasan; Mustafa Almuhaya; Abdulhamid Alnajjar; Mohammed Mofeed; Bana Nasser Journal: J Saudi Heart Assoc Date: 2020-05-12